Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma: Real-World Experience in a Monographic Oncology Center

被引:0
作者
Rios-Vinuela, E. [1 ]
Alvarez, P. [2 ]
Lavernia, J. [2 ]
Serra-Guillen, C. [1 ]
Requena, C. [1 ]
Bernia, E. [1 ]
Diago, A. [3 ]
Llombart, B. [1 ]
Sanmartin, O. [1 ]
机构
[1] Inst Valenciano Oncol, Dept Dermatol, Valencia, Spain
[2] Inst Valenciano Oncol, Dept Oncol, Valencia, Spain
[3] Hosp Univ Miguel Servet, Dept Dermatol, Zaragoza, Spain
来源
ACTAS DERMO-SIFILIOGRAFICAS | 2022年 / 113卷 / 06期
关键词
Advanced cutaneous squamous cell carcinoma; Metastatic squamous cell carcinoma; Locally-advanced squamous cell carcinoma; Cemiplimab; PD-1; inhibitorsefficacy;
D O I
10.1016/j.ad.2022.05.001
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Management of advanced cSCC is challenging, and many available systemic medications have modest efficacy. Cemiplimab has demonstrated efficacy in the treatment of advanced cSCC in clinical trials, but real-world data are still limited. With the objective of evaluating the efficacy of cemiplimab in a real-world clinical setting, we conducted a prospective observational study of 13 patients with advanced cSCC. Six patients (46%) had locally advanced disease, while 7 (54%) had metastatic disease. A total of 8 patients (62%) responded to cemiplimab. Five (38%) showed a partial response, while 3 (23%) showed a complete response. Four patients with an initial partial response presented subsequent disease progression during follow-up. Six patients (46%) developed AEs, most of which were mild (G1). PFS was 5.9 months, with a median follow-up was 9 months. In conclusion, cemiplimab demonstrated its utility in the treatment of advanced cSCC, with acceptable response rates, a remarkable number of complete responses, and a very good safety profile. (C) 2022 Published by Elsevier Espana, S.L.U. on behalf of AEDV.
引用
收藏
页码:T610 / T615
页数:6
相关论文
共 50 条
[31]   Real-Life Study of the Benefit of Concomitant Radiotherapy with Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma (cSCC): A Retrospective Cohort Study [J].
Bailly-Caille, Barbara ;
Kottler, Diane ;
Morello, Remy ;
Lecornu, Marie ;
Kao, William ;
Meyer, Emmanuel ;
Dompmartin, Anne ;
L'Orphelin, Jean-Matthieu .
CANCERS, 2023, 15 (02)
[32]   First-line programmed death-1 inhibitor treatment for locoregionally advanced or metastatic cutaneous squamous cell carcinoma - A real-world experience from Israel [J].
Averbuch, Itamar ;
Salman, Saeed ;
Shtamper, Noa ;
Doweck, Ilana ;
Popovtzer, Aron ;
Markel, Gal ;
Hendler, Daniel ;
Finkel, Inbar ;
Moore, Assaf ;
Fenig, Eyal ;
Taha, Tarek ;
Mhameed, Kamel ;
Kurman, Noga ;
Billan, Salem .
FRONTIERS IN ONCOLOGY, 2023, 13
[33]   Immunotherapy in advanced cutaneous squamous cell carcinoma: Sydney west cancer network experience [J].
Hasmat, Shaheen ;
Howle, Julie R. ;
Carlino, Matteo S. ;
Sundaresan, Puma ;
Veness, Michael J. .
ANZ JOURNAL OF SURGERY, 2023, 93 (1-2) :235-241
[34]   Anti-PD-1 therapy using cemiplimab for advanced cutaneous squamous cell carcinoma in HIV patient: A case report [J].
Alloghbi, Abdurahman ;
Ninia, James ;
Alshare, Bayan ;
Hotaling, Jeffrey ;
Raza, Syed ;
Sukari, Ammar .
CLINICAL CASE REPORTS, 2021, 9 (12)
[35]   Cemiplimab for Locally Advanced and Metastatic Cutaneous Squamous-Cell Carcinomas: Real-Life Experience from the French CAREPI Study Group [J].
Hober, Candice ;
Fredeau, Lisa ;
Pham-Ledard, Anne ;
Boubaya, Marouane ;
Herms, Florian ;
Celerier, Philippe ;
Aubin, Francois ;
Beneton, Nathalie ;
Dinulescu, Monica ;
Jannic, Arnaud ;
Meyer, Nicolas ;
Duval-Modeste, Anne-Benedicte ;
Cesaire, Laure ;
Neidhardt, Eve-Marie ;
Archier, Elodie ;
Dreno, Brigitte ;
Lesage, Candice ;
Berthin, Clemence ;
Kramkimel, Nora ;
Grange, Florent ;
de Quatrebarbes, Julie ;
Stoebner, Pierre-Emmanuel ;
Poulalhon, Nicolas ;
Arnault, Jean-Philippe ;
Abed, Safia ;
Bonniaud, Bertille ;
Darras, Sophie ;
Heidelberger, Valentine ;
Devaux, Suzanne ;
Moncourier, Marie ;
Misery, Laurent ;
Mansard, Sandrine ;
Etienne, Maxime ;
Brunet-Possenti, Florence ;
Jacobzone, Caroline ;
Lesbazeilles, Romain ;
Skowron, Francois ;
Sanchez, Julia ;
Catala, Stephanie ;
Samimi, Mahtab ;
Tazi, Youssef ;
Spaeth, Dominique ;
Gaudy-Marqueste, Caroline ;
Collard, Olivier ;
Triller, Raoul ;
Pracht, Marc ;
Dumas, Marc ;
Peuvrel, Lucie ;
Combe, Pierre ;
Lauche, Olivier .
CANCERS, 2021, 13 (14)
[36]   Advanced cutaneous squamous cell carcinoma: Impact of age on the safety and efficacy of cemiplimab and the prognostic significance of blood biomarkers [J].
Ksienski, Doran ;
Truong, Pauline T. ;
Bone, Jeffrey N. ;
Egli, Sarah ;
Clarkson, Melissa ;
Patterson, Tiffany ;
Lesperance, Mary ;
Lakkunarajah, Suganija .
JOURNAL OF GERIATRIC ONCOLOGY, 2024, 15 (05)
[37]   A Novel Intersection: Cytomegalovirus Gastritis Following Cemiplimab and Talimogene Laherparepvec in a Patient With Advanced Cutaneous Squamous Cell Carcinoma [J].
Egoryan, Goar ;
Zimmet, Alex ;
Yu, Mingwei ;
Pozdol, Joseph ;
Subramanian, Aruna ;
Reddy, Sunil ;
Nelson, Joanna .
CLINICAL CASE REPORTS, 2024, 12 (12)
[38]   IL-6 as new prognostic factor in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab [J].
Domenico Mallardo ;
Ester Simeone ;
Lucia Festino ;
Marilena Tuffanelli ;
Vito Vanella ;
Claudia Trojaniello ;
Maria Grazia Vitale ;
Margaret Ottaviano ;
Mariaelena Capone ;
Gabriele Madonna ;
Francesca Sparano ;
Eleonora Cioli ;
Luigi Scarpato ;
Marco Palla ;
Rossella Di Trolio ;
Paolo Meinardi ;
Corrado Caracò ;
Gerardo Ferrara ;
Paolo Muto ;
Ernesta Cavalcanti ;
Paolo Antonio Ascierto .
Journal of Translational Medicine, 21
[39]   IL-6 as new prognostic factor in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab [J].
Mallardo, Domenico ;
Simeone, Ester ;
Festino, Lucia ;
Tuffanelli, Marilena ;
Vanella, Vito ;
Trojaniello, Claudia ;
Vitale, Maria Grazia ;
Ottaviano, Margaret ;
Capone, Mariaelena ;
Madonna, Gabriele ;
Sparano, Francesca ;
Cioli, Eleonora ;
Scarpato, Luigi ;
Palla, Marco ;
Di Trolio, Rossella ;
Meinardi, Paolo ;
Caraco, Corrado ;
Ferrara, Gerardo ;
Muto, Paolo ;
Cavalcanti, Ernesta ;
Ascierto, Paolo Antonio .
JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)
[40]   Real-world evidence study on the early use of cemiplimab in the UK: REACT-CEMI (Real World evidence of advanced CSCC treatment with cemiplimab) [J].
Challapalli, Amarnath ;
Stewart, Grant ;
Shaw, Heather ;
Davies, Peter John ;
Lopez-Baez, Juan Carlos ;
Ottley, Edward C. ;
Kelly, Stephen .
FRONTIERS IN IMMUNOLOGY, 2024, 15